| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |